Method for detecting NANBV associated seroconversion
US7863008B2 · kind B2 · utility
0Cited by
10References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 14, 2008 |
| Grant date | Jan 4, 2011 |
| Priority date | — |
| Expiry date | Mar 17, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/82
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to recombinant expression vectors which express segments of deoxyribonucleic acid that encode recombinant HIV and HCV antigens. These recombinant expression vectors are transformed into host cells and used in a method to express large quantities of these antigens. The invention also provides compositions containing certain of the isolated antigens, diagnostic systems containing these antigens and methods of assaying body fluids to detect the presence of antibodies against the antigens of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.